{"_id": "18784455|None", "id": "18784455", "infons": {}, "passages": [{"infons": {"journal": "AIDS; 2008 Oct 01; 22(15) 1919-27. doi:10.1097/QAD.0b013e32830e011f", "year": "2008", "article-id_pmc": "PMC2675161", "type": "title", "authors": "Gupta SK, Rosenkranz SL, Cramer YS, Koletar SL, Szczech LA, Amorosa V, Hall SD", "section": "Title"}, "offset": 0, "text": "The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "efavirenz", "locations": [{"offset": 45, "length": 9}]}, {"id": "6", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "lopinavir", "locations": [{"offset": 59, "length": 9}]}, {"id": "7", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "ritonavir", "locations": [{"offset": 69, "length": 9}]}, {"id": "8", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 82, "length": 12}]}, {"id": "9", "infons": {"identifier": "9606", "type": "Species"}, "text": "persons", "locations": [{"offset": 95, "length": 7}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 127, "text": "OBJECTIVE: To evaluate the pharmacokinetics and pharmacogenomics of efavirenz (EFV) and lopinavir/ritonavir (LPV/RTV) in HIV-infected persons requiring hemodialysis. DESIGN: Prospective, observational study of HIV-infected hemodialysis patients receiving one 600 mg tablet daily of EFV (N = 13) or three 133.3/33.3 mg capsules twice daily of LPV/RTV (N = 13). METHODS: Twenty-four-hour EFV and 12-h LPV/RTV pharmacokinetics were assessed. Geometric mean ratios were calculated using historical controls with normal renal function. The effects of several candidate gene polymorphisms were also explored. RESULTS: The geometric mean [95% confidence interval (CI); percentage of coefficient of variation (% CV)] Cmin, Cmax, and area under the curve (AUC) for the EFV group were 1.81 microg/ml (0.93, 3.53; 103%), 5.04 microg/ml (3.48, 7.29; 72%), and 71.5 microg h/ml (43.2, 118.3; 93%), respectively. These parameters were 2.76 microg/ml (1.86, 4.11; 53%), 8.45 microg/ml (6.41, 11.15; 52%), and 69.6 microg h/ml (55.6, 87.2; 37%) for LPV and 0.08 microg/ml (0.05, 0.14; 63%), 0.58 microg/ml (0.44, 0.76; 41%), and 3.74 microg h/ml (2.91, 4.80; 37%) for RTV. The AUC geometric mean ratios (90% CI) for EFV, LPV, and RTV were 132% (89, 197), 81% (67, 97), and 92% (76, 111), respectively. LPV Cmin was lower than expected in the hemodialysis group. Higher EFV concentrations were associated with the CYP2B6 516G&gt;T polymorphism. CONCLUSION: The pharmacokinetics of EFV and LPV/RTV in hemodialysis suggests that no dosing adjustments are necessary in treatment-naive patients. As HIV-infected hemodialysis patients are disproportionately black, the increased frequency of the CYP2B6 516G&gt;T polymorphism may lead to higher EFV levels. The potentially lower LPV trough levels in this population suggest that LPV/RTV should be used with caution in protease-inhibitor-experienced patients.", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "efavirenz", "locations": [{"offset": 195, "length": 9}]}, {"id": "31", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 206, "length": 3}]}, {"id": "32", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "lopinavir", "locations": [{"offset": 215, "length": 9}]}, {"id": "33", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "ritonavir", "locations": [{"offset": 225, "length": 9}]}, {"id": "34", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected", "locations": [{"offset": 248, "length": 12}]}, {"id": "35", "infons": {"identifier": "9606", "type": "Species"}, "text": "persons", "locations": [{"offset": 261, "length": 7}]}, {"id": "36", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected hemodialysis", "locations": [{"offset": 337, "length": 25}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 363, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 409, "length": 3}]}, {"id": "39", "infons": {"identifier": "MESH:D061466", "type": "Chemical"}, "text": "LPV", "locations": [{"offset": 469, "length": 3}]}, {"id": "40", "infons": {"identifier": "MESH:D019438", "type": "Chemical"}, "text": "RTV", "locations": [{"offset": 473, "length": 3}]}, {"id": "41", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 513, "length": 3}]}, {"id": "42", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 887, "length": 3}]}, {"id": "43", "infons": {"identifier": "1555", "type": "Gene", "ncbi_homologene": "73894"}, "text": "CYP2B6", "locations": [{"offset": 1524, "length": 6}]}, {"id": "44", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1692, "length": 8}]}, {"id": "45", "infons": {"identifier": "MESH:D015658", "type": "Disease"}, "text": "HIV-infected hemodialysis", "locations": [{"offset": 1705, "length": 25}]}, {"id": "46", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 1731, "length": 8}]}, {"id": "47", "infons": {"identifier": "1555", "type": "Gene", "ncbi_homologene": "73894"}, "text": "CYP2B6", "locations": [{"offset": 1801, "length": 6}]}, {"id": "48", "infons": {"identifier": "MESH:C098320", "type": "Chemical"}, "text": "EFV", "locations": [{"offset": 1850, "length": 3}]}, {"id": "49", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 2004, "length": 8}]}], "relations": []}], "relations": [], "pmid": 18784455, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D015658", "chemical@MESH:D019438", "species@9606", "gene@1555", "chemical@MESH:C098320", "chemical@MESH:D061466"], "journal": "AIDS", "year": 2008, "authors": ["Gupta SK", "Rosenkranz SL", "Cramer YS", "Koletar SL", "Szczech LA", "Amorosa V", "Hall SD"]}